Krishana Phoschem Q1 FY27: Growth Holds Up Amid Raw Material Volatility

Krishana Phoschem Limited opened FY27 with a quarter that mixed strong year on year growth with a clearly tougher operating backdrop. For Q1 FY27, revenue from operations rose to 532.3 crore, up 34.6 percent versus Q1 FY26. EBITDA excluding other income increased to 89.0 crore, up 35.7 percent, while profit after tax climbed to 47.1 crore, up about 54 percent.

Management attributed the performance to the company’s integrated manufacturing setup, diversified sourcing, and disciplined working capital management, even as global supply disruptions and geopolitical uncertainty kept input costs elevated. The quarter also captured the seasonal nature of the business. Management explained that Q4 is typically stronger than Q1, which helped contextualize the sequential revenue decline from Q4 FY26 to Q1 FY27.

A notable feature of the quarter was the divergence between the two key fertilizer lines operationally. SSP ran at very high utilization, while NPK/DAP utilization was lower in Q1. Management linked this primarily to raw material availability constraints, and stated that supply conditions have since improved, with expectations of better utilization in Q2 and the rest of FY27.

Financial performance and what changed sequentially

The company’s Q1 FY27 profitability was supported by healthier operating margins. EBITDA margin for Q1 FY27 was reported at 16.7 percent, broadly in line with Q1 FY26 and sharply higher than Q4 FY26.

However, PAT margin was lower than Q4 FY26. Management explained that the sequential dip in PAT margin was largely due to a sharp rise in depreciation and finance costs after commissioning of new capacities. As per the financial summary table in the presentation, depreciation rose to 13.7 crore in Q1 FY27 from 8.7 crore in Q4 FY26, and finance costs rose to 20.8 crore from 13.5 crore. Management’s view was that this is an expected step-up after capex commissioning and that operating leverage should improve as utilization ramps up.

The call also provided partial color on the revenue mix. Management stated that about 173 crore of Q1 FY27 revenue came from trading and the remainder from manufacturing. Trading EBITDA margins were indicated around 7 to 8 percent, while manufacturing margins were described as around 16 percent on average, varying with product mix.

Operations: utilization gaps and product mix shift

Operationally, management acknowledged that Q1 FY27 was impacted by raw material availability and logistics challenges. The presentation showed SSP utilization running above 100 percent, while NPK/DAP utilization was significantly lower in Q1 FY27 than in the preceding quarters.

On the call, management said the issue was not capacity, but raw material availability. With supplies now described as smoother, the company expects NPK/DAP utilization to improve in Q2.

Another lever discussed in the quarter was product mix. The company expanded its complex fertilizer portfolio by launching additional variants during Q1 FY27, including 12:32:16, 16:20:0:13, 15:15:15, 8:21:21, and 9:24:24. Management linked stronger-than-expected EBITDA in Q1 to a combination of improved product mix, cost efficiencies, selling price improvements, and also acknowledged that lower-cost inventory carried from the previous quarter contributed to higher EBITDA margins.

For Q1 FY27 volumes shared on the call, management indicated NPK/DAP sales of about 53,500 MT, SSP sales of about 36,300 MT, and trading volumes of about 21,000 MT.

Strategy and long cycle initiatives: capacity, integration, and green ammonia

The strategic narrative in the investor presentation remains centered on integration and scale expansion. The presentation highlights installed capacity of 6.15 lakh MTPA and captive intermediates including BRP beneficiation, sulphuric acid and phosphoric acid.

Capacity expansion completed by March 31, 2026 was referenced in both the presentation and the chairman’s quote, notably the NPK/DAP capacity addition of 165,000 MTPA and sulphuric acid capacity addition of 99,000 MTPA at Meghnagar. Management expects a steady ramp-up over the remaining quarters of FY27.

A key long-cycle initiative is the 10-year green ammonia purchase agreement with SECI for 70,000 MTPA under the National Green Hydrogen Mission framework. While the presentation emphasized benefits like supply security, margin resilience, and decarbonization alignment, the concall clarified timing and economics. Management stated the supply is expected to begin in FY29. It also explained a pricing mechanism designed to keep its effective cost at or below prevailing grey ammonia pricing, which is intended to support competitiveness once the arrangement starts.

On market context, management highlighted supportive tailwinds including improved monsoon conditions later in early July, higher MSPs for Kharif crops, and continued government support through the Nutrient Based Subsidy framework. At the same time, management acknowledged risks from geopolitical disruptions affecting shipping routes and input price inflation, particularly sulphur prices which were described as volatile and influenced by uncertainty around the Strait of Hormuz.

Takeaways

Krishana Phoschem’s Q1 FY27 results delivered strong year on year growth in revenue, EBITDA, and PAT despite a quarter shaped by elevated input prices and logistics disruption. The near-term focus is on improving NPK/DAP utilization after raw material constraints in Q1, and sustaining margins through product mix and integration benefits.

Management commentary also set expectations for a stronger run-rate across the remaining quarters of FY27, with an expressed target of quarterly turnover above 500 crore for the rest of the year and incremental turnover growth of around 30 to 35 percent over last year. Over the longer horizon, the green ammonia arrangement beginning FY29 is positioned as a structural input-cost and supply-security lever, while the expanded capacities at Meghnagar remain central to the next phase of operating leverage.